![Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical](https://cdn2.caymanchem.com/cdn/cms/caymanchem/PublishingImages/Lists/NewsItems/AllItems/cannabinoid%20signaling%20figure%202.png)
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
![The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience & The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &](https://onlinelibrary.wiley.com/cms/asset/944d0127-7289-44d4-b51d-d149bc6fb6da/cns13848-toc-0001-m.png)
The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &
![Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/31/11/3799/F3.large.jpg)
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research
![The structure of synthetic cannabinoid agonists WIN 55,212-2 (WIN).... | Download Scientific Diagram The structure of synthetic cannabinoid agonists WIN 55,212-2 (WIN).... | Download Scientific Diagram](https://www.researchgate.net/publication/286993189/figure/fig1/AS:621213151932416@1525120165303/The-structure-of-synthetic-cannabinoid-agonists-WIN-55-212-2-WIN-Molecular-formula.png)
The structure of synthetic cannabinoid agonists WIN 55,212-2 (WIN).... | Download Scientific Diagram
![Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1 Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1](https://www.spandidos-publications.com/article_images/mmr/13/6/MMR-13-06-4569-g05.jpg)
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
![The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells | Prostate Cancer and Prostatic Diseases The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fpcan.2016.19/MediaObjects/41391_2016_Article_BFpcan201619_Fig1_HTML.jpg)
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells | Prostate Cancer and Prostatic Diseases
![WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... | Download Scientific Diagram WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... | Download Scientific Diagram](https://www.researchgate.net/profile/Dale-Fortin/publication/7306030/figure/fig7/AS:668548166873097@1536405712775/WIN55-212-2-WIN-a-cannabinoid-receptor-agonist-suppresses-EPSCs-evoked-from-layer-5.png)
WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... | Download Scientific Diagram
![Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-d-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons | Journal of Pharmacology and Experimental Therapeutics Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-d-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/331/3/1062/F1.large.jpg)
Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-d-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons | Journal of Pharmacology and Experimental Therapeutics
![Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212‐2 alters migration of early‐born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex - Saez - 2014 - Journal Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212‐2 alters migration of early‐born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex - Saez - 2014 - Journal](https://onlinelibrary.wiley.com/cms/asset/98a14448-2697-442d-a2ff-a3f261e97c7e/jnc12636-fig-0008-m.jpg)
Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212‐2 alters migration of early‐born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex - Saez - 2014 - Journal
![The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/37/11/6341/F1.large.jpg)
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research
![Gestational exposure to the cannabinoid WIN 55,212-2 and its effect on the innate intestinal immune response | Scientific Reports Gestational exposure to the cannabinoid WIN 55,212-2 and its effect on the innate intestinal immune response | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-56653-y/MediaObjects/41598_2019_56653_Fig1_HTML.png)
Gestational exposure to the cannabinoid WIN 55,212-2 and its effect on the innate intestinal immune response | Scientific Reports
![Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin](https://www.mdpi.com/receptors/receptors-01-00002/article_deploy/html/images/receptors-01-00002-g001.png)
Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin
![Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical](https://cdn2.caymanchem.com/cdn/cms/caymanchem/PublishingImages/Lists/NewsItems/AllItems/cannabinoid%20signaling%20figure%201.png)
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
![Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes | eNeuro Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes | eNeuro](https://www.eneuro.org/content/eneuro/7/5/ENEURO.0144-20.2020/F1.large.jpg)
Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes | eNeuro
![Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1 Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1](https://www.spandidos-publications.com/article_images/mmr/13/6/MMR-13-06-4569-g02.jpg)
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
![Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity - Mouro - 2018 - Journal of Neurochemistry - Wiley Online Library Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity - Mouro - 2018 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ff97484f-053a-41a9-b254-cf3681454b11/jnc14549-fig-0006-m.png)